These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 890698)

  • 41. Advanced prostatic cancer revisited--35 years later.
    Jacobo E; Culp DA
    J Iowa Med Soc; 1977 Feb; 67(2):52-5. PubMed ID: 839097
    [No Abstract]   [Full Text] [Related]  

  • 42. Melphalan (NSC-8806) in advanced breast cancer.
    Sears ME; Haut A; Eckles N
    Cancer Chemother Rep; 1966 Jul; 50(5):271-9. PubMed ID: 5936997
    [No Abstract]   [Full Text] [Related]  

  • 43. Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.
    Canada A; Herman L; Kidd K; Robertson C; Trump D
    Cancer Chemother Pharmacol; 1993; 32(1):73-7. PubMed ID: 8462127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.
    Smith DC; Jodrell DI; Egorin MJ; Ambinder RM; Zuhowski EG; Kreis W; Ellis PG; Trump DL
    Cancer Chemother Pharmacol; 1993; 31(5):363-8. PubMed ID: 7679331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melphalan in metastatic cancer of the prostate: a pilot study.
    Franks CR
    Cancer Treat Rep; 1979 Feb; 63(2):228-9. PubMed ID: 445500
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro cytotoxic effect of melphalan and pilot phase II study in hormone-refractory prostate cancer.
    Mougenot P; Bressolle F; Culine S; Solassol I; Poujol S; Pinguet F
    Anticancer Res; 2006; 26(3B):2197-203. PubMed ID: 16821586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
    Sarfaty GA; Alder SJ; McLean RG
    Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ketoconazole in advanced prostate cancer.
    Percy LA
    Ann Pharmacother; 1992 Dec; 26(12):1527-9. PubMed ID: 1482810
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chemotherapy of prostatic cancer].
    Portnoĭ AS
    Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
    [No Abstract]   [Full Text] [Related]  

  • 51. Melphalan in advanced prostatic cancer: a pilot study.
    Houghton AL; Robinson MR; Smith PH
    Cancer Treat Rep; 1977 Aug; 61(5):923-4. PubMed ID: 890698
    [No Abstract]   [Full Text] [Related]  

  • 52. Flutamide monotherapy as primary treatment in advanced prostatic carcinoma.
    Delaere KP; Van Thillo EL
    Semin Oncol; 1991 Oct; 18(5 Suppl 6):13-8. PubMed ID: 1948117
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.